Kuros Biosciences AG (SWX:KURN)

Kuros Biosciences AG Ratios and Metrics

Market cap in millions CHF. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 12, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,016	806	128	54	63	66
Market Cap Growth	20.37%	528.00%	138.81%	-14.90%	-4.70%	20.42%
Enterprise Value	1,000	793	114	34	38	54
Last Close Price	25.94	21.35	3.49	1.47	1.93	2.02
PS Ratio	9.83	10.66	3.82	2.99	4.57	16.40
PB Ratio	13.26	13.71	2.26	0.78	0.82	0.78
P/TBV Ratio	29.17	33.12	8.15	2.67	3.01	2.45
P/FCF Ratio	-	393.96	-	-	-	-
P/OCF Ratio	1239.28	256.57	-	-	-	-
EV/Sales Ratio	9.67	10.50	3.41	1.90	2.77	13.27
EV/EBITDA Ratio	154.07	385.86	-	-	-	-
EV/EBIT Ratio	259.29	7414.24	-	-	-	-
EV/FCF Ratio	-1483.02	387.93	-	-	-	-
Debt / Equity Ratio	0.02	0.03	0.04	0.03	0.03	0.03
Debt / EBITDA Ratio	0.28	0.66	-	-	-	-
Debt / FCF Ratio	-	0.88	-	-	-	-
Net Debt / Equity Ratio	-0.22	-0.28	-0.21	-0.32	-0.34	-0.31
Net Debt / EBITDA Ratio	-2.86	-7.89	4.04	2.95	4.17	2.74
Net Debt / FCF Ratio	24.71	-7.93	1.32	2.86	4.58	2.79
Asset Turnover	1.10	0.97	0.44	0.21	0.15	0.04
Inventory Turnover	1.14	1.18	1.27	1.47	2.33	1.96
Quick Ratio	1.68	1.64	2.22	2.20	2.72	7.69
Current Ratio	2.25	2.14	2.77	2.49	2.91	8.76
Return on Equity (ROE)	-8.62%	-6.44%	-16.18%	-20.02%	-9.33%	-14.18%
Return on Assets (ROA)	2.57%	0.09%	-4.12%	-7.06%	-5.90%	-8.09%
Return on Capital Employed (ROCE)	4.60%	0.20%	-8.20%	-14.00%	-11.00%	-13.00%
Earnings Yield	-0.60%	-0.53%	-10.70%	-27.17%	-11.95%	-17.39%
FCF Yield	-0.07%	0.25%	-7.14%	-14.41%	-9.13%	-14.04%
Buyback Yield / Dilution	-36.07%	-1.69%	-7.91%	-3.37%	-34.86%	-53.69%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.